CURO Biosciences Secures ₹16 cr for advancing saliva-based cancer detection tech https://ift.tt/xFGvI2T

ErlySign’s innovation is a biomarker-based test kit capable of detecting oral precancerous conditions within just 15 minutes using a simple, non-invasive saliva sample.

from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/iRuojBN